醫(yī)療機構(gòu)在優(yōu)化院內(nèi)藥品結(jié)構(gòu)、合理調(diào)整藥品目錄的工作中，對待遴選藥品進行多維度綜合評價對保障臨床基本用藥的供應(yīng)與規(guī)范使用具有重要意義。國內(nèi)在藥品遴選及評價方法方面的研究相對薄弱，與國外存在較大差距，且目前國內(nèi)現(xiàn)有的藥品遴選評價方法由于評價策略和指標體系存在較大的差異性，給醫(yī)療機構(gòu)的選擇帶來了困惑。因此，根據(jù)國內(nèi)實際情況，制定符合醫(yī)療機構(gòu)藥品準入與調(diào)出工作實際的藥品遴選評價方法至關(guān)重要。通過對國內(nèi)現(xiàn)有藥品遴選評價方法進行分析，并結(jié)合自身工作實踐，提出構(gòu)建符合國內(nèi)醫(yī)療機構(gòu)藥品目錄動態(tài)調(diào)整工作實際的藥品遴選評價方法的策略建議，為醫(yī)療機構(gòu)規(guī)范開展藥品遴選評價工作提供參考。

In optimizing the internal drug structure and properly adjusting the drug catalog, it is of significant importance for medical institutions to perform a multidimensional comprehensive evaluation of selected drugs to ensure the supply and proper use of essential drugs in clinical settings. Research on drug selection and evaluation methods within domestic institutions is relatively weak compared to foreign countries, and there is a significant gap. Additionally, the existing drug selection and evaluation methods in domestic institutions have caused confusion due to substantial differences in evaluation strategies and indicator systems. Therefore, it is crucial to develop drug selection and evaluation methods tailored to the actual conditions of drug access and removal in medical institutions based on the domestic situation. This paper analyzes the existing domestic drug selection and evaluation methods and proposes strategic suggestions for developing drug selection and evaluation methods that align with the practical dynamics of drug catalog adjustment in Chinese medical institutions, providing a reference for standardizing drug selection and evaluation work in medical institutions.

R97

廣東省醫(yī)學(xué)科學(xué)技術(shù)研究基金項目（A2023283）；廣東省醫(yī)院藥學(xué)研究基金項目（2024A17）；深圳市衛(wèi)生經(jīng)濟學(xué)會科研基金項目（202414）